Biomerica, Inc. (BMRA)
NASDAQ: BMRA · IEX Real-Time Price · USD
0.445
-0.003 (-0.56%)
At close: Jul 2, 2024, 4:00 PM
0.444
-0.001 (-0.27%)
After-hours: Jul 2, 2024, 7:53 PM EDT
Biomerica Revenue
Biomerica had revenue of $5.41M in the twelve months ending February 29, 2024, down -43.29% year-over-year. Revenue in the quarter ending February 29, 2024 was $1.02M, a -8.46% decrease year-over-year. In the fiscal year ending May 31, 2023, Biomerica had annual revenue of $5.34M, a decrease of -71.71%.
Revenue (ttm)
$5.41M
Revenue Growth
-43.29%
P/S Ratio
1.38
Revenue / Employee
$87,181
Employees
62
Market Cap
7.49M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
May 31, 2023 | 5.34M | -13.53M | -71.71% |
May 31, 2022 | 18.87M | 11.67M | 162.13% |
May 31, 2021 | 7.20M | 506.32K | 7.57% |
May 31, 2020 | 6.69M | 1.49M | 28.69% |
May 31, 2019 | 5.20M | -363.50K | -6.53% |
May 31, 2018 | 5.56M | -227.49K | -3.93% |
May 31, 2017 | 5.79M | 651.85K | 12.68% |
May 31, 2016 | 5.14M | 177.44K | 3.58% |
May 31, 2015 | 4.96M | -158.08K | -3.09% |
May 31, 2014 | 5.12M | -1.35M | -20.89% |
May 31, 2013 | 6.47M | 391.83K | 6.44% |
May 31, 2012 | 6.08M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CareMax | 810.36M |
XWELL | 31.77M |
Precipio | 15.81M |
Pulmatrix | 11.68M |
NeuroMetrix | 5.27M |
PAVmed | 3.02M |
Mainz Biomed B.V. | 895.48K |
Mangoceuticals | 844.87K |
BMRA News
- 1 day ago - Biomerica Launches At-Home Sample Collection for inFoods® IBS, Significantly Expanding Access for Millions of IBS Sufferers - GlobeNewsWire
- 7 weeks ago - Biomerica Announces inFoods® IBS Pilot Launch with Prominent 1,100 Member Physician Group Commencing June 2024 - GlobeNewsWire
- 2 months ago - Biomerica and Leading UAE Healthcare Company Forge a Path to Enhanced Colorectal and Breast Screening with Exclusive Multi-Year Distribution Agreement - GlobeNewsWire
- 2 months ago - Biomerica provides update on inFoods® IBS expansion - GlobeNewsWire
- 2 months ago - Biomerica Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 3 months ago - Biomerica InFoods IBS Data to be Presented at the Upcoming Digestive Disease Week (DDW) 2024 Conference - GlobeNewsWire
- 4 months ago - Diagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory Board - GlobeNewsWire
- 5 months ago - Diagnostics Industry Leader Jack Kenny Appointed as Chairman of the Board at Biomerica - GlobeNewsWire